Please visit www.renishaw.com/bio for further details on how Renishaw's inVia confocal Raman microscope is being used in the life sciences.

References


1 Harder et al: A Raman Spectroscopic Study of Cell Response to Clinical Doses of Ionizing Radiation: Applied Spectroscopy: Volume 69, Number 2, 2015.
2 Harder et al: Raman spectroscopy identifies radiation response in human non-small cell lung cancer xenografts; Scientific Reports; 6:21006, DOI: 10.1038/srep21006.

About Renishaw
Renishaw is one of the world's leading engineering and scientific technology companies, with expertise in precision measurement and healthcare. The company supplies products and services used in applications as diverse as jet engine and wind turbine manufacture, through to dentistry and brain surgery. It is also a world leader in the field of additive manufacturing (also referred to as 3D printing), where it is the only UK business that designs and makes industrial machines which ‘print' parts from metal powder.

The Renishaw Group currently has more than 70 offices in 33 countries, with over 4,000 employees, of which 2,700 people are employed within the UK. The majority of the company's R&D and manufacturing is carried out in the UK and for the year ended June 2015 Renishaw achieved sales of £494.7 million of which 95% was due to exports. The company's largest markets are the USA, China, South Korea, Germany and Japan.

The Company's success has been recognised with numerous international awards, including eighteen Queen's Awards recognising achievements in technology, export and innovation. Renishaw received a Queen's Award for Enterprise 2014, in the Innovations category, for the continuous development of the inVia confocal Raman microscope. For more information visit www.renishaw.com

Back to HCB News

Medical Research Homepage